China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
How did CPHI's recent EPS compare to expectations?
The most recent EPS for China Pharma Holdings Inc is $, expectations of $.
How did China Pharma Holdings Inc CPHI's revenue perform in the last quarter?
China Pharma Holdings Inc revenue for the last quarter is $
What is the revenue estimate for China Pharma Holdings Inc?
According to of Wall street analyst, the revenue estimate of China Pharma Holdings Inc range from $ to $
What's the earning quality score for China Pharma Holdings Inc?
China Pharma Holdings Inc has a earning quality score of A-/63.021378. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does China Pharma Holdings Inc report earnings?
China Pharma Holdings Inc next earnings report is expected in 2021-08-12
What are China Pharma Holdings Inc's expected earnings?
China Pharma Holdings Inc expected earnings is $, according to wall-street analysts.
Did China Pharma Holdings Inc beat earnings expectations?
China Pharma Holdings Inc recent earnings of $ expectations.